Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06934382
What this trial is testing

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Stephan Grupp MD PhD 33
Large-scale testing (Phase 3)UnknownNCT03391726
What this trial is testing

CART-19 Cells for R/R B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
Fujian Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05716087
What this trial is testing

Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma (MCL)
Guangzhou Lupeng Pharmaceutical Company LTD. 62
Testing effectiveness (Phase 2)Ended earlyNCT01078922
What this trial is testing

Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas

Who this might be right for
Non-Hodgkin Lymphomas
Oncology Specialists, S.C. 11
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Early research (Phase 1)Not Yet RecruitingNCT04595162
What this trial is testing

GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Peking University Third Hospital 12
Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Early research (Phase 1)Not Yet RecruitingNCT07113496
What this trial is testing

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

Who this might be right for
Relapsed or Refractory B-cell Hematologic MalignanciesB-cell Acute Lymphoblastic Leukemia (B-ALL)Multiple Myeloma (MM)+3 more
The First Affiliated Hospital with Nanjing Medical University 27
Early research (Phase 1)Study completedNCT03804996
What this trial is testing

Study of TG-1801 in Subjects With B-Cell Lymphoma

Who this might be right for
B-Cell Lymphoma
TG Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT02874404
What this trial is testing

TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
University of Nebraska 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658352
What this trial is testing

A First-in-Human Study of HP-002 for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Shanghai Helioson Pharmaceutical Co., Ltd. 114
Testing effectiveness (Phase 2)Ended earlyNCT03123393
What this trial is testing

TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Calithera Biosciences, Inc 49
Early research (Phase 1)Ended earlyNCT06622226
What this trial is testing

ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Ono Pharmaceutical Co., Ltd. 2
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03479268
What this trial is testing

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+15 more
City of Hope Medical Center 18
Early research (Phase 1)Not Yet RecruitingNCT07674823
What this trial is testing

Study Of KITE-753 in R/R B-Cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00336583
What this trial is testing

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Asan Medical Center 27
Early research (Phase 1)WithdrawnNCT04635683
What this trial is testing

Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueRecurrent Follicular Lymphoma+21 more
Yazeed Sawalha
Testing effectiveness (Phase 2)Ended earlyNCT04750941
What this trial is testing

Study of Copanlisib and Ketogenic Diet

Who this might be right for
Follicular LymphomaEndometrial Cancer
Columbia University 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05429268
What this trial is testing

Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)

Who this might be right for
Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma
Incyte Corporation 82
Next Page